Lab News
ACS cervical cancer guidelines disappoint some testing firms
July 31, 2020 -- Diagnostics developer Hologic has voiced disappointment with new cervical cancer screening guidelines from the American Cancer Society (ACS).
PanCan, GeneCentric partner on precision medicine for pancreatic cancer
July 31, 2020 -- The Pancreatic Cancer Action Network (PanCan) and GeneCentric Therapeutics have partnered to conduct research on RNA-based molecular technologies to predict pancreatic cancer disease progression and drug response.
Medicare to pay for Myriad's BRCA testing in prostate cancer patients
July 31, 2020 -- Medicare will be covering use of Myriad's BracAnalysis companion diagnostic in men with prostate cancer who may be eligible for treatment with the poly (ADP-ribose) polymerase inhibitor olaparib (Lynparza).
FDA approves Roche's faster Herceptin companion test
July 31, 2020 -- The U.S. Food and Drug Administration has granted approval to Roche's new Ventana dual in situ hybridization companion diagnostic, for use with the company's well-established HER2-targeted drug trastuzumab.
National cervical cancer screening guidelines shift to primary HPV testing
July 30, 2020 -- The American Cancer Society has made sweeping changes in its new cervical cancer screening guidelines published July 30, including a shift to primary HPV testing, with no cytology, as the preferred screening method.  Discuss
Thrive rakes in $257M to advance multicancer liquid biopsy
July 30, 2020 -- Cambridge, MA-based startup Thrive Earlier Detection has raised $257 million in a new round of financing, which the company plans to use to advance its CancerSeek multicancer liquid biopsy test into a "robust" trial supporting regulatory approval.
Molecular diagnostics sales surge in Hologic's Q3
July 30, 2020 -- A strong surge in sales of its molecular diagnostics products helped Hologic offset declines in other areas of the company's business in its third fiscal quarter.
FDA spurs development of COVID-19 tests for use outside labs
July 30, 2020 -- The U.S. Food and Drug Administration (FDA) has published a template to help commercial companies develop COVID-19 molecular diagnostic and antigen tests that can be used completely outside of laboratory environments and without a prescription.
AACC survey finds widespread shortage of COVID-19 testing supplies
July 30, 2020 -- Nearly half of U.S. clinical laboratories still do not have the supplies they need to run COVID-19 tests, according to a new survey conducted by the American Association for Clinical Chemistry (AACC).
Quest wins approval to increase capacity for COVID-19
July 30, 2020 -- Quest Diagnostics has received emergency use authorization from the U.S. Food and Drug Administration to test a new laboratory technique that could bolster its COVID-19 testing capacity.
Next Generation Dx Summit
August 25-27
American Society for Clinical Pathology (ASCP) Annual Meeting
September 9-11
Austin, Texas United States
Association for Molecular Pathology (AMP) Europe
September 14-16
Milan, Lombardia Italy
MedTech Conference
October 5-7
Toronto, Ontario Canada
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets